<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">32345319</PMID><DateCompleted><Year>2021</Year><Month>03</Month><Day>19</Day></DateCompleted><DateRevised><Year>2022</Year><Month>04</Month><Day>05</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1742-2094</ISSN><JournalIssue CitedMedium="Internet"><Volume>17</Volume><Issue>1</Issue><PubDate><Year>2020</Year><Month>Apr</Month><Day>28</Day></PubDate></JournalIssue><Title>Journal of neuroinflammation</Title><ISOAbbreviation>J Neuroinflammation</ISOAbbreviation></Journal><ArticleTitle>Potential of activated microglia as a source of dysregulated extracellular microRNAs contributing to neurodegeneration in amyotrophic lateral sclerosis.</ArticleTitle><Pagination><StartPage>135</StartPage><MedlinePgn>135</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">135</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12974-020-01822-4</ELocationID><Abstract><AbstractText>Amyotrophic lateral sclerosis (ALS) is the most common form of motor neuron degeneration in adults, and several mechanisms underlying the disease pathology have been proposed. It has been shown that glia communicate with other cells by releasing extracellular vesicles containing proteins and nucleic acids, including microRNAs (miRNAs), which play a role in the post-transcriptional regulation of gene expression. Dysregulation of miRNAs is commonly observed in ALS patients, together with inflammation and an altered microglial phenotype. However, the role of miRNA-containing vesicles in microglia-to-neuron communication in the context of ALS has not been explored in depth. This review summarises the evidence for the presence of inflammation, pro-inflammatory microglia and dysregulated miRNAs in ALS, then explores how microglia may potentially be responsible for this miRNA dysregulation. The possibility of pro-inflammatory ALS microglia releasing miRNAs which may then enter neuronal cells to contribute to degeneration is also explored. Based on the literature reviewed here, microglia are a likely source of dysregulated miRNAs and potential mediators of neurodegenerative processes. Therefore, dysregulated miRNAs may be promising candidates for the development of therapeutic strategies.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Christoforidou</LastName><ForeName>Eleni</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>School of Life Sciences, University of Sussex, Falmer, Brighton, BN1 9QG, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Joilin</LastName><ForeName>Greig</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>School of Life Sciences, University of Sussex, Falmer, Brighton, BN1 9QG, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hafezparast</LastName><ForeName>Majid</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-5262-7150</Identifier><AffiliationInfo><Affiliation>School of Life Sciences, University of Sussex, Falmer, Brighton, BN1 9QG, UK. M.Hafezparast@sussex.ac.uk.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>HAFEZPARAST/APR15/836-791</GrantID><Acronym>MNDA_</Acronym><Agency>Motor Neurone Disease Association</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>HAFEZPARAST/APR18/861-791</GrantID><Acronym>MNDA_</Acronym><Agency>Motor Neurone Disease Association</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>Hafezparast/Apr15/836-791</GrantID><Acronym>MNDA_</Acronym><Agency>Motor Neurone Disease Association</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>Hafezparast/Apr18/861-791</GrantID><Acronym>MNDA_</Acronym><Agency>Motor Neurone Disease Association</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>04</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Neuroinflammation</MedlineTA><NlmUniqueID>101222974</NlmUniqueID><ISSNLinking>1742-2094</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D035683">MicroRNAs</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002450" MajorTopicYN="N">Cell Communication</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000067128" MajorTopicYN="N">Extracellular Vesicles</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D035683" MajorTopicYN="N">MicroRNAs</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017628" MajorTopicYN="N">Microglia</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009410" MajorTopicYN="N">Nerve Degeneration</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">Microglia</Keyword><Keyword MajorTopicYN="N">Neurodegeneration</Keyword><Keyword MajorTopicYN="N">microRNA</Keyword></KeywordList><CoiStatement>The authors declare that they have no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>10</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>4</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>4</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>4</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>3</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32345319</ArticleId><ArticleId IdType="pmc">PMC7187511</ArticleId><ArticleId IdType="doi">10.1186/s12974-020-01822-4</ArticleId><ArticleId IdType="pii">10.1186/s12974-020-01822-4</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Chi&#xf2; A, Logroscino G, Traynor BJ, Collins J, Simeone JC, Goldstein LA, et al. Global epidemiology of amyotrophic lateral sclerosis: a systematic review of the published literature. Neuroepidemiology. 2013;41(2):118&#x2013;130.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4049265</ArticleId><ArticleId IdType="pubmed">23860588</ArticleId></ArticleIdList></Reference><Reference><Citation>Giordana MT, Ferrero P, Grifoni S, Pellerino A, Naldi A, Montuschi A. Dementia and cognitive impairment in amyotrophic lateral sclerosis: a review. Neurol Sci. 2011;32(1):9&#x2013;16.</Citation><ArticleIdList><ArticleId IdType="pubmed">20953810</ArticleId></ArticleIdList></Reference><Reference><Citation>Gorno-Tempini ML, Hillis AE, Weintraub S, Kertesz A, Mendez M, Cappa SF, et al. Classification of primary progressive aphasia and its variants. Neurology. 2011;76(11):1006&#x2013;1014.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3059138</ArticleId><ArticleId IdType="pubmed">21325651</ArticleId></ArticleIdList></Reference><Reference><Citation>Rascovsky K, Hodges JR, Knopman D, Mendez MF, Kramer JH, Neuhaus J, et al. Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. Brain. 2011;134(9):2456&#x2013;2477.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3170532</ArticleId><ArticleId IdType="pubmed">21810890</ArticleId></ArticleIdList></Reference><Reference><Citation>Kiernan MC, Vucic S, Cheah BC, Turner MR, Eisen A, Hardiman O, et al. Amyotrophic lateral sclerosis. Lancet. 2011;377(9769):942&#x2013;955.</Citation><ArticleIdList><ArticleId IdType="pubmed">21296405</ArticleId></ArticleIdList></Reference><Reference><Citation>Swinnen B, Robberecht W. The phenotypic variability of amyotrophic lateral sclerosis. Nat Rev Neurol. 2014;10:661.</Citation><ArticleIdList><ArticleId IdType="pubmed">25311585</ArticleId></ArticleIdList></Reference><Reference><Citation>Haeusler AR, Donnelly CJ, Periz G, Simko EAJ, Shaw PG, Kim M-S, et al. C9orf72 nucleotide repeat structures initiate molecular cascades of disease. Nature. 2014;507:195.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4046618</ArticleId><ArticleId IdType="pubmed">24598541</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosen DR, Siddique T, Patterson D, Figlewicz DA, Sapp P, Hentati A, et al. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature. 1993;362(6415):59&#x2013;62.</Citation><ArticleIdList><ArticleId IdType="pubmed">8446170</ArticleId></ArticleIdList></Reference><Reference><Citation>Vance C, Rogelj B, Hortob&#xe1;gyi T, De Vos KJ, Nishimura AL, Sreedharan J, et al. Mutations in FUS, an RNA processing protein, cause familial amyotrophic lateral sclerosis type 6. Science. 2009;323(5918):1208.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4516382</ArticleId><ArticleId IdType="pubmed">19251628</ArticleId></ArticleIdList></Reference><Reference><Citation>Sreedharan J, Blair IP, Tripathi VB, Hu X, Vance C, Rogelj B, et al. TDP-43 Mutations in familial and sporadic amyotrophic lateral sclerosis. Science. 2008;319(5870):1668.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7116650</ArticleId><ArticleId IdType="pubmed">18309045</ArticleId></ArticleIdList></Reference><Reference><Citation>van Es MA, Hardiman O, Chio A, Al-Chalabi A, Pasterkamp RJ, Veldink JH, et al. Amyotrophic lateral sclerosis. Lancet. 2017;390(10107):2084&#x2013;2098.</Citation><ArticleIdList><ArticleId IdType="pubmed">28552366</ArticleId></ArticleIdList></Reference><Reference><Citation>Peters OM, Ghasemi M, Brown RH., Jr Emerging mechanisms of molecular pathology in ALS. J Clin Invest. 2015;125(5):1767&#x2013;1779.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4463186</ArticleId><ArticleId IdType="pubmed">25932674</ArticleId></ArticleIdList></Reference><Reference><Citation>Saberi S, Stauffer JE, Schulte DJ, Ravits J. Neuropathology of amyotrophic lateral sclerosis and its variants. Neurol Clin. 2015;33(4):855&#x2013;876.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4628785</ArticleId><ArticleId IdType="pubmed">26515626</ArticleId></ArticleIdList></Reference><Reference><Citation>Robinson JL, Geser F, Stieber A, Umoh M, Kwong LK, Van Deerlin VM, et al. TDP-43 skeins show properties of amyloid in a subset of ALS cases. Acta Neuropathol. 2013;125(1):121&#x2013;131.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3536927</ArticleId><ArticleId IdType="pubmed">23124365</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin W-L, Dickson DW. Ultrastructural localization of TDP-43 in filamentous neuronal inclusions in various neurodegenerative diseases. Acta Neuropathol. 2008;116(2):205&#x2013;213.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2706695</ArticleId><ArticleId IdType="pubmed">18607609</ArticleId></ArticleIdList></Reference><Reference><Citation>Hasegawa M, Arai T, Nonaka T, Kametani F, Yoshida M, Hashizume Y, et al. Phosphorylated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Ann Neurol. 2008;64(1):60&#x2013;70.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2674108</ArticleId><ArticleId IdType="pubmed">18546284</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan C-F, Eguchi H, Tagawa A, Onodera O, Iwasaki T, Tsujino A, et al. TDP-43 immunoreactivity in neuronal inclusions in familial amyotrophic lateral sclerosis with or without SOD1 gene mutation. Acta Neuropathol. 2007;113(5):535&#x2013;542.</Citation><ArticleIdList><ArticleId IdType="pubmed">17333220</ArticleId></ArticleIdList></Reference><Reference><Citation>Mackenzie IRA, Bigio EH, Ince PG, Geser F, Neumann M, Cairns NJ, et al. Pathological TDP-43 distinguishes sporadic amyotrophic lateral sclerosis from amyotrophic lateral sclerosis with SOD1 mutations. Ann Neurol. 2007;61(5):427&#x2013;434.</Citation><ArticleIdList><ArticleId IdType="pubmed">17469116</ArticleId></ArticleIdList></Reference><Reference><Citation>Neumann M, Sampathu DM, Kwong LK, Truax AC, Micsenyi MC, Chou TT, et al. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science. 2006;314(5796):130.</Citation><ArticleIdList><ArticleId IdType="pubmed">17023659</ArticleId></ArticleIdList></Reference><Reference><Citation>Deng H-X, Zhai H, Bigio EH, Yan J, Fecto F, Ajroud K, et al. FUS-immunoreactive inclusions are a common feature in sporadic and non-SOD1 familial amyotrophic lateral sclerosis. Ann Neurol. 2010;67(6):739&#x2013;748.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4376270</ArticleId><ArticleId IdType="pubmed">20517935</ArticleId></ArticleIdList></Reference><Reference><Citation>Ikenaka K, Ishigaki S, Iguchi Y, Kawai K, Fujioka Y, Yokoi S, et al. Characteristic features of FUS inclusions in spinal motor neurons of sporadic amyotrophic lateral sclerosis. Journal of Neuropathology &amp; Experimental Neurology. 2020.</Citation><ArticleIdList><ArticleId IdType="pubmed">32142134</ArticleId></ArticleIdList></Reference><Reference><Citation>Tyzack GE, Luisier R, Taha DM, Neeves J, Modic M, Mitchell JS, et al. Widespread FUS mislocalization is a molecular hallmark of amyotrophic lateral sclerosis. Brain. 2019;142(9):2572&#x2013;2580.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6735815</ArticleId><ArticleId IdType="pubmed">31368485</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J, Xu G, Li H, Gonzales V, Fromholt D, Karch C, et al. Somatodendritic accumulation of misfolded SOD1-L126Z in motor neurons mediates degeneration: &#x3b1;B-crystallin modulates aggregation. Hum Mol Genet. 2005;14(16):2335&#x2013;2347.</Citation><ArticleIdList><ArticleId IdType="pubmed">16000321</ArticleId></ArticleIdList></Reference><Reference><Citation>Karch CM, Prudencio M, Winkler DD, Hart PJ, Borchelt DR. Role of mutant SOD1 disulfide oxidation and aggregation in the pathogenesis of familial ALS. Proc Natl Acad Sci U S A. 2009;106(19):7774&#x2013;7779.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2675570</ArticleId><ArticleId IdType="pubmed">19416874</ArticleId></ArticleIdList></Reference><Reference><Citation>Boston-Howes W, Gibb SL, Williams EO, Pasinelli P, Brown RH, Trotti D. Caspase-3 cleaves and inactivates the glutamate transporter EAAT2. J Biol Chem. 2006;281(20):14076&#x2013;14084.</Citation><ArticleIdList><ArticleId IdType="pubmed">16567804</ArticleId></ArticleIdList></Reference><Reference><Citation>Kikuchi H, Almer G, Yamashita S, Gu&#xe9;gan C, Nagai M, Xu Z, et al. Spinal cord endoplasmic reticulum stress associated with a microsomal accumulation of mutant superoxide dismutase-1 in an ALS model. Proc Natl Acad Sci. 2006;103(15):6025.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1458691</ArticleId><ArticleId IdType="pubmed">16595634</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishitoh H, Kadowaki H, Nagai A, Maruyama T, Yokota T, Fukutomi H, et al. ALS-linked mutant SOD1 induces ER stress- and ASK1-dependent motor neuron death by targeting Derlin-1. Genes Dev. 2008;22(11):1451&#x2013;1464.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2418582</ArticleId><ArticleId IdType="pubmed">18519638</ArticleId></ArticleIdList></Reference><Reference><Citation>Saxena S, Cabuy E, Caroni P. A role for motoneuron subtype&#x2013;selective ER stress in disease manifestations of FALS mice. Nat Neurosci. 2009;12:627.</Citation><ArticleIdList><ArticleId IdType="pubmed">19330001</ArticleId></ArticleIdList></Reference><Reference><Citation>Bruijn LI, Houseweart MK, Kato S, Anderson KL, Anderson SD, Ohama E, et al. Aggregation and motor neuron toxicity of an ALS-linked SOD1 mutant independent from wild-type SOD1. Science. 1998;281(5384):1851.</Citation><ArticleIdList><ArticleId IdType="pubmed">9743498</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoffman EK, Wilcox HM, Scott RW, Siman R. Proteasome inhibition enhances the stability of mouse Cu Zn superoxide dismutase with mutations linked to familial amyotrophic lateral sclerosis. J Neurol Sci. 1996;139(1):15&#x2013;20.</Citation><ArticleIdList><ArticleId IdType="pubmed">8836967</ArticleId></ArticleIdList></Reference><Reference><Citation>Cassina P, Cassina A, Pehar M, Castellanos R, Gandelman M, de Le&#xf3;n A, et al. Mitochondrial dysfunction in SOD1-G93A-bearing astrocytes promotes motor neuron degeneration: prevention by mitochondrial-targeted antioxidants. J Neurosci. 2008;28(16):4115.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3844766</ArticleId><ArticleId IdType="pubmed">18417691</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu J, Lillo C, Jonsson PA, Velde CV, Ward CM, Miller TM, et al. Toxicity of Familial ALS-linked SOD1 mutants from selective recruitment to spinal mitochondria. Neuron. 2004;43(1):5&#x2013;17.</Citation><ArticleIdList><ArticleId IdType="pubmed">15233913</ArticleId></ArticleIdList></Reference><Reference><Citation>Vande Velde C, Miller TM, Cashman NR, Cleveland DW. Selective association of misfolded ALS-linked mutant SOD1 with the cytoplasmic face of mitochondria. Proc Natl Acad Sci. 2008;105(10):4022.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2268797</ArticleId><ArticleId IdType="pubmed">18296640</ArticleId></ArticleIdList></Reference><Reference><Citation>Urushitani M, Sik A, Sakurai T, Nukina N, Takahashi R, Julien J-P. Chromogranin-mediated secretion of mutant superoxide dismutase proteins linked to amyotrophic lateral sclerosis. Nat Neurosci. 2006;9(1):108&#x2013;118.</Citation><ArticleIdList><ArticleId IdType="pubmed">16369483</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao W, Beers DR, Henkel JS, Zhang W, Urushitani M, Julien J-P, et al. Extracellular mutant SOD1 induces microglial-mediated motoneuron injury. Glia. 2010;58(2):231&#x2013;243.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2784168</ArticleId><ArticleId IdType="pubmed">19672969</ArticleId></ArticleIdList></Reference><Reference><Citation>Harraz MM, Marden JJ, Zhou W, Zhang Y, Williams A, Sharov VS, et al. SOD1 mutations disrupt redox-sensitive Rac regulation of NADPH oxidase in a familial ALS model. J Clin Invest. 2008;118(2):659&#x2013;670.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2213375</ArticleId><ArticleId IdType="pubmed">18219391</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhong Z, Deane R, Ali Z, Parisi M, Shapovalov Y, O'Banion MK, et al. ALS-causing SOD1 mutants generate vascular changes prior to motor neuron degeneration. Nat Neurosci. 2008;11:420.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2895310</ArticleId><ArticleId IdType="pubmed">18344992</ArticleId></ArticleIdList></Reference><Reference><Citation>Murakami T, Nagano I, Hayashi T, Manabe Y, Shoji M, Setoguchi Y, et al. Impaired retrograde axonal transport of adenovirus-mediated E. coli LacZ gene in the mice carrying mutant SOD1 gene. Neurosci Lett. 2001;308(3):149&#x2013;152.</Citation><ArticleIdList><ArticleId IdType="pubmed">11479010</ArticleId></ArticleIdList></Reference><Reference><Citation>Perlson E, Jeong G-B, Ross JL, Dixit R, Wallace KE, Kalb RG, et al. A switch in retrograde signaling from survival to stress in rapid-onset neurodegeneration. J Neurosci. 2009;29(31):9903.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3095444</ArticleId><ArticleId IdType="pubmed">19657041</ArticleId></ArticleIdList></Reference><Reference><Citation>Williamson TL, Cleveland DW. Slowing of axonal transport is a very early event in the toxicity of ALS&#x2013;linked SOD1 mutants to motor neurons. Nat Neurosci. 1999;2(1):50&#x2013;56.</Citation><ArticleIdList><ArticleId IdType="pubmed">10195180</ArticleId></ArticleIdList></Reference><Reference><Citation>De Vos KJ, Hafezparast M. Neurobiology of axonal transport defects in motor neuron diseases: opportunities for translational research? Neurobiol Dis. 2017;105:283&#x2013;299.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5536153</ArticleId><ArticleId IdType="pubmed">28235672</ArticleId></ArticleIdList></Reference><Reference><Citation>Paez-Colasante X, Figueroa-Romero C, Sakowski SA, Goutman SA, Feldman EL. Amyotrophic lateral sclerosis: mechanisms and therapeutics in the epigenomic era. Nat Rev Neurol. 2015;11:266.</Citation><ArticleIdList><ArticleId IdType="pubmed">25896087</ArticleId></ArticleIdList></Reference><Reference><Citation>Boill&#xe9;e S, Yamanaka K, Lobsiger CS, Copeland NG, Jenkins NA, Kassiotis G, et al. Onset and progression in inherited ALS determined by motor neurons and microglia. Science. 2006;312(5778):1389.</Citation><ArticleIdList><ArticleId IdType="pubmed">16741123</ArticleId></ArticleIdList></Reference><Reference><Citation>Kang SH, Li Y, Fukaya M, Lorenzini I, Cleveland DW, Ostrow LW, et al. Degeneration and impaired regeneration of gray matter oligodendrocytes in amyotrophic lateral sclerosis. Nat Neurosci. 2013;16:571.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3637847</ArticleId><ArticleId IdType="pubmed">23542689</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamanaka K, Komine O. The multi-dimensional roles of astrocytes in ALS. Neurosci Res. 2018;126:31&#x2013;38.</Citation><ArticleIdList><ArticleId IdType="pubmed">29054467</ArticleId></ArticleIdList></Reference><Reference><Citation>Lino MM, Schneider C, Caroni P. Accumulation of SOD1 mutants in postnatal motoneurons does not cause motoneuron pathology or motoneuron disease. J Neurosci. 2002;22(12):4825.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6757755</ArticleId><ArticleId IdType="pubmed">12077179</ArticleId></ArticleIdList></Reference><Reference><Citation>Pramatarova A, Lagani&#xe8;re J, Roussel J, Brisebois K, Rouleau GA. Neuron-specific expression of mutant superoxide dismutase 1 in transgenic mice does not lead to motor impairment. J Neurosci. 2001;21(10):3369.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6762496</ArticleId><ArticleId IdType="pubmed">11331366</ArticleId></ArticleIdList></Reference><Reference><Citation>Clement AM, Nguyen MD, Roberts EA, Garcia ML, Boill&#xe9;e S, Rule M, et al. Wild-type nonneuronal cells extend survival of SOD1 mutant motor neurons in ALS mice. Science. 2003;302(5642):113.</Citation><ArticleIdList><ArticleId IdType="pubmed">14526083</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamanaka K, Boillee S, Roberts EA, Garcia ML, McAlonis-Downes M, Mikse OR, et al. Mutant SOD1 in cell types other than motor neurons and oligodendrocytes accelerates onset of disease in ALS mice. Proc Natl Acad Sci. 2008;105(21):7594.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2396671</ArticleId><ArticleId IdType="pubmed">18492803</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamanaka K, Chun SJ, Boillee S, Fujimori-Tonou N, Yamashita H, Gutmann DH, et al. Astrocytes as determinants of disease progression in inherited amyotrophic lateral sclerosis. Nat Neurosci. 2008;11:251.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3137510</ArticleId><ArticleId IdType="pubmed">18246065</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang L, Gutmann DH, Roos RP. Astrocyte loss of mutant SOD1 delays ALS disease onset and progression in G85R transgenic mice. Hum Mol Genet. 2010;20(2):286&#x2013;293.</Citation><ArticleIdList><ArticleId IdType="pubmed">20962037</ArticleId></ArticleIdList></Reference><Reference><Citation>Nardo G, Pozzi S, Pignataro M, Lauranzano E, Spano G, Garbelli S, et al. Amyotrophic lateral sclerosis multiprotein biomarkers in peripheral blood mononuclear cells. Plos One. 2011;6(10):e25545.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3187793</ArticleId><ArticleId IdType="pubmed">21998667</ArticleId></ArticleIdList></Reference><Reference><Citation>Verde F, Del Tredici K, Braak H, Ludolph A. The multisystem degeneration amyotrophic lateral sclerosis - neuropathological staging and clinical translation. Arch Ital Biol. 2017;155(4):118&#x2013;130.</Citation><ArticleIdList><ArticleId IdType="pubmed">29405032</ArticleId></ArticleIdList></Reference><Reference><Citation>Beers DR, Zhao W, Liao B, Kano O, Wang J, Huang A, et al. Neuroinflammation modulates distinct regional and temporal clinical responses in ALS mice. Brain Behav Immun. 2011;25(5):1025&#x2013;1035.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3096756</ArticleId><ArticleId IdType="pubmed">21176785</ArticleId></ArticleIdList></Reference><Reference><Citation>Grosskreutz J, Van Den Bosch L, Keller BU. Calcium dysregulation in amyotrophic lateral sclerosis. Cell Calcium. 2010;47(2):165&#x2013;174.</Citation><ArticleIdList><ArticleId IdType="pubmed">20116097</ArticleId></ArticleIdList></Reference><Reference><Citation>Fiala M, Chattopadhay M, La Cava A, Tse E, Liu G, Lourenco E, et al. IL-17A is increased in the serum and in spinal cord CD8 and mast cells of ALS patients. J Neuroinflammation. 2010;7(1):76.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2992053</ArticleId><ArticleId IdType="pubmed">21062492</ArticleId></ArticleIdList></Reference><Reference><Citation>Moreau C, Devos D, Brunaud-Danel V, Defebvre L, Perez T, Dest&#xe9;e A, et al. Elevated IL-6 and TNF-&#x3b1; levels in patients with ALS: inflammation or hypoxia? Neurology. 2005;65(12):1958.</Citation><ArticleIdList><ArticleId IdType="pubmed">16380619</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuhle J, Lindberg RLP, Regeniter A, Mehling M, Steck AJ, Kappos L, et al. Increased levels of inflammatory chemokines in amyotrophic lateral sclerosis. Eur J Neurol. 2009;16(6):771&#x2013;774.</Citation><ArticleIdList><ArticleId IdType="pubmed">19236470</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitchell RM, Freeman WM, Randazzo WT, Stephens HE, Beard JL, Simmons Z, et al. A CSF biomarker panel for identification of patients with amyotrophic lateral sclerosis. Neurology. 2009;72(1):14.</Citation><ArticleIdList><ArticleId IdType="pubmed">18987350</ArticleId></ArticleIdList></Reference><Reference><Citation>Rentzos M, Rombos A, Nikolaou C, Zoga M, Zouvelou V, Dimitrakopoulos A, et al. Interleukin-15 and interleukin-12 are elevated in serum and cerebrospinal fluid of [atients with amyotrophic lateral sclerosis. Eur Neurol. 2010;63(5):285-90.</Citation><ArticleIdList><ArticleId IdType="pubmed">20407265</ArticleId></ArticleIdList></Reference><Reference><Citation>Sekizawa T, Openshaw H, Ohbo K, Sugamura K, Itoyama Y, Niland JC. Cerebrospinal fluid interleukin 6 in amyotrophic lateral sclerosis: immunological parameter and comparison with inflammatory and non-inflammatory central nervous system diseases. J Neurol Sci. 1998;154(2):194&#x2013;199.</Citation><ArticleIdList><ArticleId IdType="pubmed">9562310</ArticleId></ArticleIdList></Reference><Reference><Citation>Tateishi T, Yamasaki R, Tanaka M, Matsushita T, Kikuchi H, Isobe N, et al. CSF chemokine alterations related to the clinical course of amyotrophic lateral sclerosis. J Neuroimmunol. 2010;222(1):76&#x2013;81.</Citation><ArticleIdList><ArticleId IdType="pubmed">20381883</ArticleId></ArticleIdList></Reference><Reference><Citation>Italiani P, Carlesi C, Giungato P, Puxeddu I, Borroni B, Boss&#xf9; P, et al. Evaluating the levels of interleukin-1 family cytokines in sporadic amyotrophic lateral sclerosis. J Neuroinflammation. 2014;11(1):94.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4039322</ArticleId><ArticleId IdType="pubmed">24884937</ArticleId></ArticleIdList></Reference><Reference><Citation>Krieger C, Perry TL, Ziltener HJ. Amyotrophic Lateral Sclerosis: Interleukin-6 Levels in cerebrospinal fluid. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. 1992;19(3):357&#x2013;359.</Citation><ArticleIdList><ArticleId IdType="pubmed">1393846</ArticleId></ArticleIdList></Reference><Reference><Citation>Berjaoui S, Povedano M, Garcia-Esparcia P, Carmona M, Aso E, Ferrer I. Complex inflammation mRNA-related response in ALS is region dependent. Neural Plasticity. 2015;2015:11.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4537753</ArticleId><ArticleId IdType="pubmed">26301107</ArticleId></ArticleIdList></Reference><Reference><Citation>Glass CK, Saijo K, Winner B, Marchetto MC, Gage FH. Mechanisms underlying inflammation in neurodegeneration. Cell. 2010;140(6):918&#x2013;934.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2873093</ArticleId><ArticleId IdType="pubmed">20303880</ArticleId></ArticleIdList></Reference><Reference><Citation>Song C, Zhang Y, Dong Y. Acute and subacute IL-1&#x3b2; administrations differentially modulate neuroimmune and neurotrophic systems: possible implications for neuroprotection and neurodegeneration. J Neuroinflammation. 2013;10(1):826.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3656796</ArticleId><ArticleId IdType="pubmed">23651534</ArticleId></ArticleIdList></Reference><Reference><Citation>Meissner F, Molawi K, Zychlinsky A. Mutant superoxide dismutase 1-induced IL-1&#x3b2; accelerates ALS pathogenesis. Proc Natl Acad Sci. 2010;107(29):13046.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2919927</ArticleId><ArticleId IdType="pubmed">20616033</ArticleId></ArticleIdList></Reference><Reference><Citation>Kawamata T, Akiyama H, Yamada T, McGeer PL. Immunologic reactions in amyotrophic lateral sclerosis brain and spinal cord tissue. Am J Pathol. 1992;140(3):691&#x2013;707.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1886170</ArticleId><ArticleId IdType="pubmed">1347673</ArticleId></ArticleIdList></Reference><Reference><Citation>Papadimitriou D, Le Verche V, Jacquier A, Ikiz B, Przedborski S, Re DB. Inflammation in ALS and SMA: sorting out the good from the evil. Neurobiol Di. 2010;37(3):493&#x2013;502.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2823924</ArticleId><ArticleId IdType="pubmed">19833209</ArticleId></ArticleIdList></Reference><Reference><Citation>Sta M, Sylva-Steenland RMR, Casula M, de Jong JMBV, Troost D, Aronica E, et al. Innate and adaptive immunity in amyotrophic lateral sclerosis: evidence of complement activation. Neurobiol Dis. 2011;42(3):211&#x2013;220.</Citation><ArticleIdList><ArticleId IdType="pubmed">21220013</ArticleId></ArticleIdList></Reference><Reference><Citation>Almer G, Gu&#xe9;gan C, Teismann P, Naini A, Rosoklija G, Hays AP, et al. Increased expression of the pro-inflammatory enzyme cyclooxygenase-2 in amyotrophic lateral sclerosis. Ann Neurol. 2001;49(2):176&#x2013;185.</Citation><ArticleIdList><ArticleId IdType="pubmed">11220737</ArticleId></ArticleIdList></Reference><Reference><Citation>Casula M, Iyer AM, Spliet WGM, Anink JJ, Steentjes K, Sta M, et al. Toll-like receptor signaling in amyotrophic lateral sclerosis spinal cord tissue. Neuroscience. 2011;179:233&#x2013;243.</Citation><ArticleIdList><ArticleId IdType="pubmed">21303685</ArticleId></ArticleIdList></Reference><Reference><Citation>Kielian T. Toll-like receptors in central nervous system glial inflammation and homeostasis. J Neurosci Res. 2006;83(5):711&#x2013;730.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2440498</ArticleId><ArticleId IdType="pubmed">16541438</ArticleId></ArticleIdList></Reference><Reference><Citation>Aebischer J, Moumen A, Sazdovitch V, Seilhean D, Meininger V, Raoul C. Elevated levels of IFN&#x3b3; and LIGHT in the spinal cord of patients with sporadic amyotrophic lateral sclerosis. Eur J Neurol. 2012;19(5):752&#x2013;759.</Citation><ArticleIdList><ArticleId IdType="pubmed">22221541</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo X-G, Chen S-D. The changing phenotype of microglia from homeostasis to disease. Translational Neurodegeneration. 2012;1(1):9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3514090</ArticleId><ArticleId IdType="pubmed">23210447</ArticleId></ArticleIdList></Reference><Reference><Citation>Lynch MA. The multifaceted profile of activated microglia. Mol Neurobiol. 2009;40(2):139&#x2013;156.</Citation><ArticleIdList><ArticleId IdType="pubmed">19629762</ArticleId></ArticleIdList></Reference><Reference><Citation>Ousman SS, Kubes P. Immune surveillance in the central nervous system. Nat Neurosci. 2012;15:1096.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7097282</ArticleId><ArticleId IdType="pubmed">22837040</ArticleId></ArticleIdList></Reference><Reference><Citation>Rock RB, Gekker G, Hu S, Sheng WS, Cheeran M, Lokensgard JR, et al. Role of microglia in central nervous system infections. Clin Microbiol Rev. 2004;17(4):942.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC523558</ArticleId><ArticleId IdType="pubmed">15489356</ArticleId></ArticleIdList></Reference><Reference><Citation>Kettenmann H, Hanisch U-K, Noda M, Verkhratsky A. Physiology of microglia. Physiol Rev. 2011;91(2):461&#x2013;553.</Citation><ArticleIdList><ArticleId IdType="pubmed">21527731</ArticleId></ArticleIdList></Reference><Reference><Citation>Dawson VL, Dawson TM, Bartley DA, Uhl GR, Snyder SH. Mechanisms of nitric oxide-mediated neurotoxicity in primary brain cultures. J Neurosci. 1993;13(6):2651.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6576487</ArticleId><ArticleId IdType="pubmed">7684776</ArticleId></ArticleIdList></Reference><Reference><Citation>Tanaka M, Sotomatsu A, Yoshida T, Hirai S, Nishida A. Detection of superoxide production by activated microglia using a sensitive and specific chemiluminescence assay and microglia-mediated PC12h cell death. J Neurochem. 1994;63(1):266&#x2013;270.</Citation><ArticleIdList><ArticleId IdType="pubmed">8207432</ArticleId></ArticleIdList></Reference><Reference><Citation>Davalos D, Grutzendler J, Yang G, Kim JV, Zuo Y, Jung S, et al. ATP mediates rapid microglial response to local brain injury in vivo. Nat Neurosci. 2005;8(6):752&#x2013;758.</Citation><ArticleIdList><ArticleId IdType="pubmed">15895084</ArticleId></ArticleIdList></Reference><Reference><Citation>Nimmerjahn A, Kirchhoff F, Helmchen F. Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo. Science. 2005;308(5726):1314.</Citation><ArticleIdList><ArticleId IdType="pubmed">15831717</ArticleId></ArticleIdList></Reference><Reference><Citation>Timmerman R, Burm SM, Bajramovic JJ. An overview of in vitro methods to study microglia. Front Cell Neurosci. 2018;12:242.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6087748</ArticleId><ArticleId IdType="pubmed">30127723</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu X, Leak RK, Shi Y, Suenaga J, Gao Y, Zheng P, et al. Microglial and macrophage polarization&#x2014;new prospects for brain repair. Nat Rev Neurol. 2015;11(1):56&#x2013;64.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4395497</ArticleId><ArticleId IdType="pubmed">25385337</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiu Isaac M, Morimoto Emiko TA, Goodarzi H, Liao Jennifer T, O&#x2019;Keeffe S, Phatnani Hemali P, et al. A neurodegeneration-specific gene-expression signature of acutely isolated microglia from an amyotrophic lateral sclerosis mouse model. Cell Rep. 2013;4(2):385&#x2013;401.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4272581</ArticleId><ArticleId IdType="pubmed">23850290</ArticleId></ArticleIdList></Reference><Reference><Citation>Hall ED, Oostveen JA, Gurney ME. Relationship of microglial and astrocytic activation to disease onset and progression in a transgenic model of familial ALS. Glia. 1998;23(3):249&#x2013;256.</Citation><ArticleIdList><ArticleId IdType="pubmed">9633809</ArticleId></ArticleIdList></Reference><Reference><Citation>McGeer PL, Kawamata T, Walker DG, Akiyama H, Tooyama I, McGeer EG. Microglia in degenerative neurological disease. Glia. 1993;7(1):84&#x2013;92.</Citation><ArticleIdList><ArticleId IdType="pubmed">8423066</ArticleId></ArticleIdList></Reference><Reference><Citation>Polazzi E, Monti B. Polazzi, E and Monti, B. Microglia and neuroprotection: from in vitro studies to therapeutic applications. Prog Neurobiol 92: 293-315. Prog Neurobiol. 2010;92:293&#x2013;315.</Citation><ArticleIdList><ArticleId IdType="pubmed">20609379</ArticleId></ArticleIdList></Reference><Reference><Citation>North RA. Molecular physiology of P2X receptors. Physiol Rev. 2002;82(4):1013&#x2013;1067.</Citation><ArticleIdList><ArticleId IdType="pubmed">12270951</ArticleId></ArticleIdList></Reference><Reference><Citation>Yiangou Y, Facer P, Durrenberger P, Chessell IP, Naylor A, Bountra C, et al. COX-2, CB2 and P2X7-immunoreactivities are increased in activated microglial cells/macrophages of multiple sclerosis and amyotrophic lateral sclerosis spinal cord. BMC Neurol. 2006;6(1):12.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1413551</ArticleId><ArticleId IdType="pubmed">16512913</ArticleId></ArticleIdList></Reference><Reference><Citation>D'Ambrosi N, Finocchi P, Apolloni S, Cozzolino M, Ferri A, Padovano V, et al. The proinflammatory action of microglial P2 receptors is enhanced in SOD1 models for amyotrophic lateral sclerosis. J Immunol. 2009;183(7):4648.</Citation><ArticleIdList><ArticleId IdType="pubmed">19734218</ArticleId></ArticleIdList></Reference><Reference><Citation>Apolloni S, Parisi C, Pesaresi MG, Rossi S, Carr&#xec; MT, Cozzolino M, et al. The NADPH oxidase pathway is dysregulated by the P2X7 receptor in the SOD1-G93A microglia model of amyotrophic lateral sclerosis. J Immunol. 2013;190(10):5187.</Citation><ArticleIdList><ArticleId IdType="pubmed">23589615</ArticleId></ArticleIdList></Reference><Reference><Citation>Parisi C, Napoli G, Pelegrin P, Volont&#xe9; C. M1 and M2 functional imprinting of primary microglia: role of P2X7 activation and miR-125b. Mediators of Inflamm. 2016;2016:9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5206439</ArticleId><ArticleId IdType="pubmed">28090150</ArticleId></ArticleIdList></Reference><Reference><Citation>Corcia P, Tauber C, Vercoullie J, Arlicot N, Prunier C, Praline J, et al. Molecular imaging of microglial activation in amyotrophic lateral sclerosis. PLOS ONE. 2013;7(12):e52941.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3534121</ArticleId><ArticleId IdType="pubmed">23300829</ArticleId></ArticleIdList></Reference><Reference><Citation>Turner MR, Cagnin A, Turkheimer FE, Miller CCJ, Shaw CE, Brooks DJ, et al. Evidence of widespread cerebral microglial activation in amyotrophic lateral sclerosis: an [11C](R)-PK11195 positron emission tomography study. Neurobiol Dis. 2004;15(3):601&#x2013;609.</Citation><ArticleIdList><ArticleId IdType="pubmed">15056468</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiao Q, Zhao W, Beers DR, Yen AA, Xie W, Henkel JS, et al. Mutant SOD1G93A microglia are more neurotoxic relative to wild-type microglia. J Neurochem. 2007;102(6):2008&#x2013;2019.</Citation><ArticleIdList><ArticleId IdType="pubmed">17555556</ArticleId></ArticleIdList></Reference><Reference><Citation>Liao B, Zhao W, Beers DR, Henkel JS, Appel SH. Transformation from a neuroprotective to a neurotoxic microglial phenotype in a mouse model of ALS. Exp Neurol. 2012;237(1):147&#x2013;152.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4126417</ArticleId><ArticleId IdType="pubmed">22735487</ArticleId></ArticleIdList></Reference><Reference><Citation>Beers DR, Henkel JS, Xiao Q, Zhao W, Wang J, Yen AA, et al. Wild-type microglia extend survival in PU.1 knockout mice with familial amyotrophic lateral sclerosis. Proc Natl Acad Sci. 2006;103(43):16021.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1613228</ArticleId><ArticleId IdType="pubmed">17043238</ArticleId></ArticleIdList></Reference><Reference><Citation>Frakes Ashley E, Ferraiuolo L, Haidet-Phillips Amanda M, Schmelzer L, Braun L, Miranda Carlos J, et al. Microglia induce motor neuron death via the classical NF-&#x3ba;B pathway in amyotrophic lateral sclerosis. Neuron. 2014;81(5):1009&#x2013;1023.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3978641</ArticleId><ArticleId IdType="pubmed">24607225</ArticleId></ArticleIdList></Reference><Reference><Citation>Maruyama H, Morino H, Ito H, Izumi Y, Kato H, Watanabe Y, et al. Mutations of optineurin in amyotrophic lateral sclerosis. Nature. 2010;465:223.</Citation><ArticleIdList><ArticleId IdType="pubmed">20428114</ArticleId></ArticleIdList></Reference><Reference><Citation>Swarup V, Phaneuf D, Dupr&#xe9; N, Petri S, Strong M, Kriz J, et al. Deregulation of TDP-43 in amyotrophic lateral sclerosis triggers nuclear factor &#x3ba;B&#x2013;mediated pathogenic pathways. J Exp Med. 2011;208(12):2429.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3256969</ArticleId><ArticleId IdType="pubmed">22084410</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu G, Wu C-J, Zhao Y, Ashwell JD. Optineurin negatively regulates TNF&#x3b1;- induced NF-&#x3ba;B activation by competing with NEMO for ubiquitinated RIP. Curr Biol. 2007;17(16):1438&#x2013;1443.</Citation><ArticleIdList><ArticleId IdType="pubmed">17702576</ArticleId></ArticleIdList></Reference><Reference><Citation>Fendrick SE, Xue Q-S, Streit WJ. Formation of multinucleated giant cells and microglial degeneration in rats expressing a mutant Cu/Zn superoxide dismutase gene. J Neuroinflamm. 2007;4(1):9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1808448</ArticleId><ArticleId IdType="pubmed">17328801</ArticleId></ArticleIdList></Reference><Reference><Citation>El Oussini H, Bayer H, Scekic-Zahirovic J, Vercruysse P, Sinniger J, Dirrig-Grosch S, et al. Serotonin 2B receptor slows disease progression and prevents degeneration of spinal cord mononuclear phagocytes in amyotrophic lateral sclerosis. Acta Neuropathol. 2016;131(3):465&#x2013;480.</Citation><ArticleIdList><ArticleId IdType="pubmed">26744351</ArticleId></ArticleIdList></Reference><Reference><Citation>Butovsky O, Siddiqui S, Gabriely G, Lanser AJ, Dake B, Murugaiyan G, et al. Modulating inflammatory monocytes with a unique microRNA gene signature ameliorates murine ALS. J Clin Invest. 2012;122(9):3063&#x2013;3087.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3428086</ArticleId><ArticleId IdType="pubmed">22863620</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanchez-Mejias E, Navarro V, Jimenez S, Sanchez-Mico M, Sanchez-Varo R, Nu&#xf1;ez-Diaz C, et al. Soluble phospho-tau from Alzheimer&#x2019;s disease hippocampus drives microglial degeneration. Acta Neuropathol. 2016;132(6):897&#x2013;916.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5106501</ArticleId><ArticleId IdType="pubmed">27743026</ArticleId></ArticleIdList></Reference><Reference><Citation>Lewis C-AB, Solomon JN, Rossi FM, Krieger C. Bone marrow-derived cells in the central nervous system of a mouse model of amyotrophic lateral sclerosis are associated with blood vessels and express CX3CR1. Glia. 2009;57(13):1410&#x2013;1419.</Citation><ArticleIdList><ArticleId IdType="pubmed">19243075</ArticleId></ArticleIdList></Reference><Reference><Citation>Zondler L, M&#xfc;ller K, Khalaji S, Bliederh&#xe4;user C, Ruf WP, Grozdanov V, et al. Peripheral monocytes are functionally altered and invade the CNS in ALS patients. Acta Neuropathol. 2016;132(3):391&#x2013;411.</Citation><ArticleIdList><ArticleId IdType="pubmed">26910103</ArticleId></ArticleIdList></Reference><Reference><Citation>Kunis G, Baruch K, Miller O, Schwartz M. Immunization with a myelin-derived antigen activates the brain's choroid plexus for recruitment of immunoregulatory cells to the CNS and attenuates disease progression in a mouse model of ALS. J Neurosci. 2015;35(16):6381.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6605216</ArticleId><ArticleId IdType="pubmed">25904790</ArticleId></ArticleIdList></Reference><Reference><Citation>Keren-Shaul H, Spinrad A, Weiner A, Matcovitch-Natan O, Dvir-Szternfeld R, Ulland TK, et al. A unique microglia type associated with restricting development of Alzheimer&#x2019;s disease. Cell. 2017;169(7):1276&#x2013;90.e17.</Citation><ArticleIdList><ArticleId IdType="pubmed">28602351</ArticleId></ArticleIdList></Reference><Reference><Citation>Krasemann S, Madore C, Cialic R, Baufeld C, Calcagno N, El Fatimy R, et al. The TREM2-APOE pathway drives the transcriptional phenotype of dysfunctional microglia in neurodegenerative diseases. Immunity. 2017;47(3):566&#x2013;81.e9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5719893</ArticleId><ArticleId IdType="pubmed">28930663</ArticleId></ArticleIdList></Reference><Reference><Citation>Ofengeim D, Mazzitelli S, Ito Y, DeWitt JP, Mifflin L, Zou C, et al. RIPK1 mediates a disease-associated microglial response in Alzheimer&#x2019;s disease. Proc Natl Acad Sci. 2017;114(41):E8788.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5642727</ArticleId><ArticleId IdType="pubmed">28904096</ArticleId></ArticleIdList></Reference><Reference><Citation>Kamphuis W, Kooijman L, Schetters S, Orre M, Hol EM. Transcriptional profiling of CD11c-positive microglia accumulating around amyloid plaques in a mouse model for Alzheimer's disease. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 2016;1862(10):1847&#x2013;1860.</Citation><ArticleIdList><ArticleId IdType="pubmed">27425031</ArticleId></ArticleIdList></Reference><Reference><Citation>Holtman IR, Raj DD, Miller JA, Schaafsma W, Yin Z, Brouwer N, et al. Induction of a common microglia gene expression signature by aging and neurodegenerative conditions: a co-expression meta-analysis. Acta Neuropathologica Communications. 2015;3(1):31.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4489356</ArticleId><ArticleId IdType="pubmed">26001565</ArticleId></ArticleIdList></Reference><Reference><Citation>Mrdjen D, Pavlovic A, Hartmann FJ, Schreiner B, Utz SG, Leung BP, et al. High-dimensional single-cell mapping of central nervous system immune cells reveals distinct myeloid subsets in health, aging, and disease. Immunity. 2018;48(2):380&#x2013;95.e6.</Citation><ArticleIdList><ArticleId IdType="pubmed">29426702</ArticleId></ArticleIdList></Reference><Reference><Citation>Olah M, Patrick E, Villani A-C, Xu J, White CC, Ryan KJ, et al. A transcriptomic atlas of aged human microglia. Nat Commun. 2018;9(1):539.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5803269</ArticleId><ArticleId IdType="pubmed">29416036</ArticleId></ArticleIdList></Reference><Reference><Citation>Friedman BA, Srinivasan K, Ayalon G, Meilandt WJ, Lin H, Huntley MA, et al. Diverse brain myeloid expression profiles reveal distinct microglial activation states and aspects of Alzheimer&#x2019;s disease Not Evident in Mouse Models. Cell Rep. 2018;22(3):832&#x2013;847.</Citation><ArticleIdList><ArticleId IdType="pubmed">29346778</ArticleId></ArticleIdList></Reference><Reference><Citation>Spiller KJ, Restrepo CR, Khan T, Dominique MA, Fang TC, Canter RG, et al. Microglia-mediated recovery from ALS-relevant motor neuron degeneration in a mouse model of TDP-43 proteinopathy. Nat Neurosci. 2018;21(3):329&#x2013;340.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5857237</ArticleId><ArticleId IdType="pubmed">29463850</ArticleId></ArticleIdList></Reference><Reference><Citation>Deczkowska A, Keren-Shaul H, Weiner A, Colonna M, Schwartz M, Amit I. Disease-associated microglia: a universal immune sensor of neurodegeneration. Cell. 2018;173(5):1073&#x2013;1081.</Citation><ArticleIdList><ArticleId IdType="pubmed">29775591</ArticleId></ArticleIdList></Reference><Reference><Citation>Butovsky O, Weiner HL. Microglial signatures and their role in health and disease. Nat Rev Neurosci. 2018;19(10):622&#x2013;635.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7255106</ArticleId><ArticleId IdType="pubmed">30206328</ArticleId></ArticleIdList></Reference><Reference><Citation>Cribbs DH, Berchtold NC, Perreau V, Coleman PD, Rogers J, Tenner AJ, et al. Extensive innate immune gene activation accompanies brain aging, increasing vulnerability to cognitive decline and neurodegeneration: a microarray study. J Neuroinflammation. 2012;9(1):179.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3419089</ArticleId><ArticleId IdType="pubmed">22824372</ArticleId></ArticleIdList></Reference><Reference><Citation>Ajmone-Cat MA, Onori A, Toselli C, Stronati E, Morlando M, Bozzoni I, et al. Increased FUS levels in astrocytes leads to astrocyte and microglia activation and neuronal death. Sci Rep. 2019;9(1):4572.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6418113</ArticleId><ArticleId IdType="pubmed">30872738</ArticleId></ArticleIdList></Reference><Reference><Citation>Bennett JP, Keeney PM, Brohawn DG. RNA sequencing reveals small and variable contributions of infectious agents to transcriptomes of postmortem nervous tissues from amyotrophic lateral sclerosis, Alzheimer&#x2019;s disease and Parkinson&#x2019;s disease subjects, and increased expression of genes from disease-activated microglia. Front Neurosci. 2019;13:235.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6447612</ArticleId><ArticleId IdType="pubmed">30983949</ArticleId></ArticleIdList></Reference><Reference><Citation>Erny D. Hrab&#x11b; de Angelis AL, Jaitin D, Wieghofer P, Staszewski O, David E, et al. Host microbiota constantly control maturation and function of microglia in the CNS. Na Neurosci. 2015;18(7):965&#x2013;977.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5528863</ArticleId><ArticleId IdType="pubmed">26030851</ArticleId></ArticleIdList></Reference><Reference><Citation>Wright ML, Fournier C, Houser MC, Tansey M, Glass J, Hertzberg VS. Potential role of the gut microbiome in ALS: a systematic review. Biol Res Nurs. 2018;20(5):513&#x2013;521.</Citation><ArticleIdList><ArticleId IdType="pubmed">29925252</ArticleId></ArticleIdList></Reference><Reference><Citation>McCombe PA, Henderson RD, Lee A, Lee JD, Woodruff TM, Restuadi R, et al. Gut microbiota in ALS: possible role in pathogenesis? Expert Review of Neurotherapeutics. 2019:1&#x2013;21.</Citation><ArticleIdList><ArticleId IdType="pubmed">31122082</ArticleId></ArticleIdList></Reference><Reference><Citation>Ezzi SA, Urushitani M, Julien J-P. Wild-type superoxide dismutase acquires binding and toxic properties of ALS-linked mutant forms through oxidation. J Neurochem. 2007;102(1):170&#x2013;178.</Citation><ArticleIdList><ArticleId IdType="pubmed">17394546</ArticleId></ArticleIdList></Reference><Reference><Citation>Roberts K, Zeineddine R, Corcoran L, Li W, Campbell IL, Yerbury JJ. Extracellular aggregated Cu/Zn superoxide dismutase activates microglia to give a cytotoxic phenotype. Glia. 2013;61(3):409&#x2013;419.</Citation><ArticleIdList><ArticleId IdType="pubmed">23281114</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao W, Beers DR, Bell S, Wang J, Wen S, Baloh RH, et al. TDP-43 activates microglia through NF-&#x3ba;B and NLRP3 inflammasome. Exp Neurol. 2015;273:24&#x2013;35.</Citation><ArticleIdList><ArticleId IdType="pubmed">26222336</ArticleId></ArticleIdList></Reference><Reference><Citation>Block ML, Zecca L, Hong J-S. Microglia-mediated neurotoxicity: uncovering the molecular mechanisms. Nat Rev Neurosci. 2007;8:57.</Citation><ArticleIdList><ArticleId IdType="pubmed">17180163</ArticleId></ArticleIdList></Reference><Reference><Citation>Heneka MT, Kummer MP, Latz E. Innate immune activation in neurodegenerative disease. Nature Reviews Immunology. 2014;14:463.</Citation><ArticleIdList><ArticleId IdType="pubmed">24962261</ArticleId></ArticleIdList></Reference><Reference><Citation>Lijia Z, Zhao S, Wang X, Wu C, Yang J. A self-propelling cycle mediated by reactive oxide species and nitric oxide exists in LPS-activated microglia. Neurochem Int. 2012;61(7):1220&#x2013;1230.</Citation><ArticleIdList><ArticleId IdType="pubmed">23000131</ArticleId></ArticleIdList></Reference><Reference><Citation>Neniskyte U, Brown GC. Analysis of microglial production of reactive oxygen and nitrogen species. In: Joseph B, Venero JL, editors. Microglia: methods and protocols. Totowa, NJ: Humana Press; 2013. pp. 103&#x2013;111.</Citation><ArticleIdList><ArticleId IdType="pubmed">23813374</ArticleId></ArticleIdList></Reference><Reference><Citation>Kang J, Rivest S. MyD88-deficient bone marrow cells accelerate onset and reduce survival in a mouse model of amyotrophic lateral sclerosis. J Cell Biol. 2007;179(6):1219&#x2013;1230.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2140021</ArticleId><ArticleId IdType="pubmed">18086918</ArticleId></ArticleIdList></Reference><Reference><Citation>Trudler D, Farfara D, Frenkel D. Toll-like receptors expression and signaling in glia cells in neuro-amyloidogenic diseases: towards future therapeutic application. Mediators Inflammation. 2010;2010:12.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2913815</ArticleId><ArticleId IdType="pubmed">20706642</ArticleId></ArticleIdList></Reference><Reference><Citation>Tong L, Prieto GA, Kram&#xe1;r EA, Smith ED, Cribbs DH, Lynch G, et al. Brain-derived neurotrophic factor-dependent synaptic plasticity is suppressed by interleukin-1&#x3b2; via p38 mitogen-activated protein kinase. J Neurosci. 2012;32(49):17714.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3687587</ArticleId><ArticleId IdType="pubmed">23223292</ArticleId></ArticleIdList></Reference><Reference><Citation>Centonze D, Muzio L, Rossi S, Cavasinni F, De Chiara V, Bergami A, et al. Inflammation triggers synaptic alteration and degeneration in experimental autoimmune encephalomyelitis. J Neurosci. 2009;29(11):3442.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6665268</ArticleId><ArticleId IdType="pubmed">19295150</ArticleId></ArticleIdList></Reference><Reference><Citation>Pascual O, Ben Achour S, Rostaing P, Triller A, Bessis A. Microglia activation triggers astrocyte-mediated modulation of excitatory neurotransmission. Proc Natl Acad Sci. 2012;109(4):E197.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3268269</ArticleId><ArticleId IdType="pubmed">22167804</ArticleId></ArticleIdList></Reference><Reference><Citation>Rossi S, Muzio L, De Chiara V, Grasselli G, Musella A, Musumeci G, et al. Impaired striatal GABA transmission in experimental autoimmune encephalomyelitis. Brain Behav Immun. 2011;25(5):947&#x2013;956.</Citation><ArticleIdList><ArticleId IdType="pubmed">20940040</ArticleId></ArticleIdList></Reference><Reference><Citation>Viviani B, Bartesaghi S, Gardoni F, Vezzani A, Behrens MM, Bartfai T, et al. Interleukin-1&#x3b2; enhances NMDA receptor-mediated intracellular calcium increase through activation of the Src family of kinases. J Neurosci. 2003;23(25):8692.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6740426</ArticleId><ArticleId IdType="pubmed">14507968</ArticleId></ArticleIdList></Reference><Reference><Citation>Weber A, Wasiliew P, Kracht M. Interleukin-1 (IL-1) pathway. Sci Signal. 2010;3(105):cm1.</Citation><ArticleIdList><ArticleId IdType="pubmed">20086235</ArticleId></ArticleIdList></Reference><Reference><Citation>Tremblay M-&#xc8;, Stevens B, Sierra A, Wake H, Bessis A, Nimmerjahn A. The role of microglia in the healthy brain. J Neurosci. 2011;31(45):16064.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6633221</ArticleId><ArticleId IdType="pubmed">22072657</ArticleId></ArticleIdList></Reference><Reference><Citation>Wake H, Moorhouse AJ, Jinno S, Kohsaka S, Nabekura J. Resting microglia directly monitor the functional state of synapses in vivo and determine the fate of ischemic terminals. J Neurosci. 2009;29(13):3974.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6665392</ArticleId><ArticleId IdType="pubmed">19339593</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Y, Dissing-Olesen L, MacVicar BA, Stevens B. Microglia: dynamic mediators of synapse development and plasticity. TrendsImmunol. 2015;36(10):605&#x2013;613.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4841266</ArticleId><ArticleId IdType="pubmed">26431938</ArticleId></ArticleIdList></Reference><Reference><Citation>Rothstein JD, Tsai G, Kuncl RW, Clawson L, Cornblath DR, Drachman DB, et al. Abnormal excitatory amino acid metabolism in amyotrophic lateral sclerosis. Ann Neurol. 1990;28(1):18&#x2013;25.</Citation><ArticleIdList><ArticleId IdType="pubmed">2375630</ArticleId></ArticleIdList></Reference><Reference><Citation>Rothstein JD, Van Kammen M, Levey AI, Martin LJ, Kuncl RW. Selective loss of glial glutamate transporter GLT-1 in amyotrophic lateral sclerosis. Ann Neurol. 1995;38(1):73&#x2013;84.</Citation><ArticleIdList><ArticleId IdType="pubmed">7611729</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao W, Xie W, Le W, Beers DR, He Y, Henkel JS, et al. Activated microglia initiate motor neuron injury by a nitric oxide and glutamate-mediated mechanism. J Neuropathol Exp Neurol. 2004;63(9):964&#x2013;977.</Citation><ArticleIdList><ArticleId IdType="pubmed">15453095</ArticleId></ArticleIdList></Reference><Reference><Citation>Takeuchi H, Jin S, Wang J, Zhang G, Kawanokuchi J, Kuno R, et al. Tumor necrosis factor-&#x3b1; induces neurotoxicity via glutamate release from hemichannels of activated microglia in an autocrine manner. J Biol Chem. 2006;281(30):21362&#x2013;21368.</Citation><ArticleIdList><ArticleId IdType="pubmed">16720574</ArticleId></ArticleIdList></Reference><Reference><Citation>Takeuchi H, Mizoguchi H, Doi Y, Jin S, Noda M, Liang J, et al. Blockade of gap junction hemichannel suppresses disease progression in mouse models of amyotrophic lateral sclerosis and Alzheimer's disease. PloS One. 2011;6(6):e21108.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3119678</ArticleId><ArticleId IdType="pubmed">21712989</ArticleId></ArticleIdList></Reference><Reference><Citation>Sasabe J, Chiba T, Yamada M, Okamoto K, Nishimoto I, Matsuoka M, et al. D-serine is a key determinant of glutamate toxicity in amyotrophic lateral sclerosis. EMBO J. 2007;26(18):4149&#x2013;4159.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2230675</ArticleId><ArticleId IdType="pubmed">17762863</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y, Stankovic R, Cullen KM, Meininger V, Garner B, Coggan S, et al. The kynurenine pathway and inflammation in amyotrophic lateral sclerosis. Neurotox Res. 2010;18(2):132&#x2013;142.</Citation><ArticleIdList><ArticleId IdType="pubmed">19921535</ArticleId></ArticleIdList></Reference><Reference><Citation>Petrov D, Mansfield C, Moussy A, Hermine O. ALS clinical trials review: 20&#x2009;years of failure. are we any closer to registering a new treatment? Front Aging Neurosci. 2017;9:&#x2013;68.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5360725</ArticleId><ArticleId IdType="pubmed">28382000</ArticleId></ArticleIdList></Reference><Reference><Citation>Krol J, Loedige I, Filipowicz W. The widespread regulation of microRNA biogenesis, function and decay. Nat Rev Genet. 2010;11:597.</Citation><ArticleIdList><ArticleId IdType="pubmed">20661255</ArticleId></ArticleIdList></Reference><Reference><Citation>Filipowicz W, Bhattacharyya SN, Sonenberg N. Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight? Nat Rev Genet. 2008;9:102.</Citation><ArticleIdList><ArticleId IdType="pubmed">18197166</ArticleId></ArticleIdList></Reference><Reference><Citation>Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell. 2009;136(2):215&#x2013;233.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3794896</ArticleId><ArticleId IdType="pubmed">19167326</ArticleId></ArticleIdList></Reference><Reference><Citation>Lykke-Andersen J. Identification of a human decapping complex associated with hUpf proteins in nonsense-mediated decay. Mol Cell Biol. 2002;22(23):8114&#x2013;8121.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC134073</ArticleId><ArticleId IdType="pubmed">12417715</ArticleId></ArticleIdList></Reference><Reference><Citation>Parker R, Song H. The enzymes and control of eukaryotic mRNA turnover. Nat Struct Mol Biol. 2004;11(2):121&#x2013;127.</Citation><ArticleIdList><ArticleId IdType="pubmed">14749774</ArticleId></ArticleIdList></Reference><Reference><Citation>van Dijk E, Cougot N, Meyer S, Babajko S, Wahle E, S&#xe9;raphin B. Human Dcp2: a catalytically active mRNA decapping enzyme located in specific cytoplasmic structures. EMBO J. 2002;21(24):6915&#x2013;24.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC139098</ArticleId><ArticleId IdType="pubmed">12486012</ArticleId></ArticleIdList></Reference><Reference><Citation>Bagga S, Bracht J, Hunter S, Massirer K, Holtz J, Eachus R, et al. Regulation by let-7 and lin-4 miRNAs Results in Target mRNA Degradation. Cell. 2005;122(4):553&#x2013;563.</Citation><ArticleIdList><ArticleId IdType="pubmed">16122423</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo H, Ingolia NT, Weissman JS, Bartel DP. Mammalian microRNAs predominantly act to decrease target mRNA levels. Nature. 2010;466:835.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2990499</ArticleId><ArticleId IdType="pubmed">20703300</ArticleId></ArticleIdList></Reference><Reference><Citation>Pillai RS, Bhattacharyya SN, Artus CG, Zoller T, Cougot N, Basyuk E, et al. Inhibition of translational initiation by Let-7 microRNA in human cells. Science. 2005;309(5740):1573.</Citation><ArticleIdList><ArticleId IdType="pubmed">16081698</ArticleId></ArticleIdList></Reference><Reference><Citation>Thomson DW, Bracken CP, Goodall GJ. Experimental strategies for microRNA target identification. Nucleic Acids Res. 2011;39(16):6845&#x2013;6853.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3167600</ArticleId><ArticleId IdType="pubmed">21652644</ArticleId></ArticleIdList></Reference><Reference><Citation>Babak T, Zhang W, Morris Q, Blencowe BJ, Hughes TR. Probing microRNAs with microarrays: tissue specificity and functional inference. RNA. 2004;10(11):1813&#x2013;1819.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1370668</ArticleId><ArticleId IdType="pubmed">15496526</ArticleId></ArticleIdList></Reference><Reference><Citation>Schonrock N, Ke YD, Humphreys D, Staufenbiel M, Ittner LM, Preiss T, et al. Neuronal microRNA deregulation in response to Alzheimer's disease amyloid-&#x3b2;. PLOS ONE. 2010;5(6):e11070.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2884018</ArticleId><ArticleId IdType="pubmed">20552018</ArticleId></ArticleIdList></Reference><Reference><Citation>Sempere LF, Freemantle S, Pitha-Rowe I, Moss E, Dmitrovsky E, Ambros V. Expression profiling of mammalian microRNAs uncovers a subset of brain-expressed microRNAs with possible roles in murine and human neuronal differentiation. Genome Biol. 2004;5(3):R13.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC395763</ArticleId><ArticleId IdType="pubmed">15003116</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao F-B. Context-dependent functions of specific microRNAs in neuronal development. Neural Dev. 2010;5(1):25.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2958854</ArticleId><ArticleId IdType="pubmed">20920300</ArticleId></ArticleIdList></Reference><Reference><Citation>McNeill E, Van Vactor D. microRNAs shape the neuronal landscape. Neuron. 2012;75(3):363&#x2013;379.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3441179</ArticleId><ArticleId IdType="pubmed">22884321</ArticleId></ArticleIdList></Reference><Reference><Citation>Schratt G. microRNAs at the synapse. Nat Rev Neurosci. 2009;10:842.</Citation><ArticleIdList><ArticleId IdType="pubmed">19888283</ArticleId></ArticleIdList></Reference><Reference><Citation>Morlando M, Dini Modigliani S, Torrelli G, Rosa A, Di Carlo V, Caffarelli E, et al. FUS stimulates microRNA biogenesis by facilitating co-transcriptional Drosha recruitment. EMBO J. 2012;31(24):4502&#x2013;4510.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3545295</ArticleId><ArticleId IdType="pubmed">23232809</ArticleId></ArticleIdList></Reference><Reference><Citation>Kawahara Y, Mieda-Sato A. TDP-43 promotes microRNA biogenesis as a component of the Drosha and Dicer complexes. Proc Natl Acad Sci. 2012;109(9):3347.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3295278</ArticleId><ArticleId IdType="pubmed">22323604</ArticleId></ArticleIdList></Reference><Reference><Citation>Benigni M, Ricci C, Jones AR, Giannini F, Al-Chalabi A, Battistini S. Identification of miRNAs as potential biomarkers in cerebrospinal fluid from amyotrophic lateral sclerosis patients. Neuro Mol Med. 2016;18(4):551&#x2013;560.</Citation><ArticleIdList><ArticleId IdType="pubmed">27119371</ArticleId></ArticleIdList></Reference><Reference><Citation>de Andrade HMT, de Albuquerque M, Avansini SH, de S. Rocha C, Dogini DB, Nucci A, et al. MicroRNAs-424 and 206 are potential prognostic markers in spinal onset amyotrophic lateral sclerosis. J Neurol Sci. 2016;368:19&#x2013;24.</Citation><ArticleIdList><ArticleId IdType="pubmed">27538595</ArticleId></ArticleIdList></Reference><Reference><Citation>De Felice B, Annunziata A, Fiorentino G, Borra M, Biffali E, Coppola C, et al. miR-338-3p is over-expressed in blood, CFS, serum and spinal cord from sporadic amyotrophic lateral sclerosis patients. Neurogenetics. 2014;15(4):243&#x2013;253.</Citation><ArticleIdList><ArticleId IdType="pubmed">25130371</ArticleId></ArticleIdList></Reference><Reference><Citation>Freischmidt A, M&#xfc;ller K, Ludolph AC, Weishaupt JH. Systemic dysregulation of TDP-43 binding microRNAs in amyotrophic lateral sclerosis. Acta Neuropathologica Communications. 2013;1:42.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3893596</ArticleId><ArticleId IdType="pubmed">24252274</ArticleId></ArticleIdList></Reference><Reference><Citation>Freischmidt A, M&#xfc;ller K, Zondler L, Weydt P, Mayer B, von Arnim CAF, et al. Serum microRNAs in sporadic amyotrophic lateral sclerosis. Neurobiol Aging. 2015;36(9):2660.e15&#x2013;2660.e20.</Citation><ArticleIdList><ArticleId IdType="pubmed">26142125</ArticleId></ArticleIdList></Reference><Reference><Citation>Freischmidt A, M&#xfc;ller K, Zondler L, Weydt P, Volk AE, Bo&#x17e;i&#x10d; AL, et al. Serum microRNAs in patients with genetic amyotrophic lateral sclerosis and pre-manifest mutation carriers. Brain. 2014;137(11):2938&#x2013;2950.</Citation><ArticleIdList><ArticleId IdType="pubmed">25193138</ArticleId></ArticleIdList></Reference><Reference><Citation>Katsu M, Hama Y, Utsumi J, Takashina K, Yasumatsu H, Mori F, et al. MicroRNA expression profiles of neuron-derived extracellular vesicles in plasma from patients with amyotrophic lateral sclerosis. Neurosci Lett. 2019;708:134176.</Citation><ArticleIdList><ArticleId IdType="pubmed">31173847</ArticleId></ArticleIdList></Reference><Reference><Citation>Matamala JM, Arias-Carrasco R, Sanchez C, Uhrig M, Bargsted L, Matus S, et al. Genome-wide circulating microRNA expression profiling reveals potential biomarkers for amyotrophic lateral sclerosis. Neurobiol Aging. 2018;64:123&#x2013;138.</Citation><ArticleIdList><ArticleId IdType="pubmed">29458840</ArticleId></ArticleIdList></Reference><Reference><Citation>Raheja R, Regev K, Healy BC, Mazzola MA, Beynon V, Von Glehn F, et al. Correlating serum micrornas and clinical parameters in amyotrophic lateral sclerosis. Muscle Nerve. 2018;58(2):261&#x2013;269.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6103911</ArticleId><ArticleId IdType="pubmed">29466830</ArticleId></ArticleIdList></Reference><Reference><Citation>Saucier D, Wajnberg G, Roy J, Beauregard A-P, Chacko S, Crapoulet N, et al. Identification of a circulating miRNA signature in extracellular vesicles collected from amyotrophic lateral sclerosis patients. Brain Res. 1708;2019:100&#x2013;108.</Citation><ArticleIdList><ArticleId IdType="pubmed">30552897</ArticleId></ArticleIdList></Reference><Reference><Citation>Sheinerman KS, Toledo JB, Tsivinsky VG, Irwin D, Grossman M, Weintraub D, et al. Circulating brain-enriched microRNAs as novel biomarkers for detection and differentiation of neurodegenerative diseases. Alzheimer's Res Ther. 2017;9(1):89.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5679501</ArticleId><ArticleId IdType="pubmed">29121998</ArticleId></ArticleIdList></Reference><Reference><Citation>Takahashi I, Hama Y, Matsushima M, Hirotani M, Kano T, Hohzen H, et al. Identification of plasma microRNAs as a biomarker of sporadic amyotrophic lateral sclerosis. Mol Brain. 2015;8(1):67.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4619470</ArticleId><ArticleId IdType="pubmed">26497046</ArticleId></ArticleIdList></Reference><Reference><Citation>Tasca E, Pegoraro V, Merico A, Angelini C. Circulating microRNAs as biomarkers of muscle differentiation and atrophy in ALS. Clin Neuropathol. 2016;35(1):22&#x2013;30.</Citation><ArticleIdList><ArticleId IdType="pubmed">26588026</ArticleId></ArticleIdList></Reference><Reference><Citation>Toivonen JM, Manzano R, Oliv&#xe1;n S, Zaragoza P, Garc&#xed;a-Redondo A, Osta R. MicroRNA-206: a potential circulating biomarker candidate for amyotrophic lateral sclerosis. PLOS ONE. 2014;9(2):e89065.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3930686</ArticleId><ArticleId IdType="pubmed">24586506</ArticleId></ArticleIdList></Reference><Reference><Citation>Waller R, Goodall EF, Milo M, Cooper-Knock J, Da Costa M, Hobson E, et al. Serum miRNAs miR-206, 143-3p and 374b-5p as potential biomarkers for amyotrophic lateral sclerosis (ALS) Neurobiol Aging. 2017;55:123&#x2013;131.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5455071</ArticleId><ArticleId IdType="pubmed">28454844</ArticleId></ArticleIdList></Reference><Reference><Citation>Waller R, Wyles M, Heath PR, Kazoka M, Wollff H, Shaw PJ, et al. Small RNA sequencing of sporadic amyotrophic lateral sclerosis cerebrospinal fluid reveals differentially expressed miRNAs related to neural and glial activity. Front Neurosci. 2018;11:731.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5767269</ArticleId><ArticleId IdType="pubmed">29375285</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu Q, Zhao Y, Zhou X, Luan J, Cui Y, Han J. Comparison of the extraction and determination of serum exosome and miRNA in serum and the detection of miR-27a-3p in serum exosome of ALS patients. Intractable Rare Dis Res. 2018;7(1):13&#x2013;18.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5849619</ArticleId><ArticleId IdType="pubmed">29552440</ArticleId></ArticleIdList></Reference><Reference><Citation>Joilin G, Leigh PN, Newbury SF, Hafezparast M. An overview of microRNAs as biomarkers of ALS. Front Neurol. 2019;10:186.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6416171</ArticleId><ArticleId IdType="pubmed">30899244</ArticleId></ArticleIdList></Reference><Reference><Citation>Ricci C, Marzocchi C, Battistini S. MicroRNAs as biomarkers in amyotrophic lateral sclerosis. Cells. 2018;7(11).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6262636</ArticleId><ArticleId IdType="pubmed">30463376</ArticleId></ArticleIdList></Reference><Reference><Citation>Varcianna A, Myszczynska MA, Castelli LM, O'Neill B, Kim Y, Talbot J, et al. Micro-RNAs secreted through astrocyte-derived extracellular vesicles cause neuronal network degeneration in C9orf72 ALS. EBioMedicine. 2019;40:626&#x2013;635.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6413467</ArticleId><ArticleId IdType="pubmed">30711519</ArticleId></ArticleIdList></Reference><Reference><Citation>Liguori M, Nuzziello N, Introna A, Consiglio A, Licciulli F, D&#x2019;Errico E, et al. Dysregulation of MicroRNAs and target genes networks in peripheral blood of patients with sporadic amyotrophic lateral sclerosis. Front Mol Neurosci. 2018;11:288.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6121079</ArticleId><ArticleId IdType="pubmed">30210287</ArticleId></ArticleIdList></Reference><Reference><Citation>Campos-Melo D, Droppelmann CA, He Z, Volkening K, Strong MJ. Altered microRNA expression profile in amyotrophic lateral sclerosis: a role in the regulation of NFL mRNA levels. Mol Brain. 2013;6(1):26.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3668997</ArticleId><ArticleId IdType="pubmed">23705811</ArticleId></ArticleIdList></Reference><Reference><Citation>Figueroa-Romero C, Hur J, Lunn JS, Paez-Colasante X, Bender DE, Yung R, et al. Expression of microRNAs in human post-mortem amyotrophic lateral sclerosis spinal cords provides insight into disease mechanisms. Mol Cell Neurosci. 2016;71:34&#x2013;45.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4761498</ArticleId><ArticleId IdType="pubmed">26704906</ArticleId></ArticleIdList></Reference><Reference><Citation>Emde A, Eitan C, Liou L-L, Libby RT, Rivkin N, Magen I, et al. Dysregulated miRNA biogenesis downstream of cellular stress and ALS-causing mutations: a new mechanism for ALS. EMBO J. 2015;34(21):2633&#x2013;2651.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4641530</ArticleId><ArticleId IdType="pubmed">26330466</ArticleId></ArticleIdList></Reference><Reference><Citation>Rizzuti M, Filosa G, Melzi V, Calandriello L, Dioni L, Bollati V, et al. MicroRNA expression analysis identifies a subset of downregulated miRNAs in ALS motor neuron progenitors. Sci Rep. 2018;8(1):10105.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6031650</ArticleId><ArticleId IdType="pubmed">29973608</ArticleId></ArticleIdList></Reference><Reference><Citation>Bruneteau G, Simonet T, Bauch&#xe9; S, Mandjee N, Malfatti E, Girard E, et al. Muscle histone deacetylase 4 upregulation in amyotrophic lateral sclerosis: potential role in reinnervation ability and disease progression. Brain. 2013;136(8):2359&#x2013;2368.</Citation><ArticleIdList><ArticleId IdType="pubmed">23824486</ArticleId></ArticleIdList></Reference><Reference><Citation>Jensen L, J&#xf8;rgensen LH, Bech RD, Frandsen U, Schr&#xf8;der HD. Skeletal muscle remodelling as a function of disease progression in amyotrophic lateral sclerosis. Biomed Res Int. 2016;2016:5930621.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4852332</ArticleId><ArticleId IdType="pubmed">27195289</ArticleId></ArticleIdList></Reference><Reference><Citation>Kovanda A, Leonardis L, Zidar J, Koritnik B, Dolenc-Groselj L, Ristic Kovacic S, et al. Differential expression of microRNAs and other small RNAs in muscle tissue of patients with ALS and healthy age-matched controls. Sci Rep. 2018;8(1):5609.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5884852</ArticleId><ArticleId IdType="pubmed">29618798</ArticleId></ArticleIdList></Reference><Reference><Citation>Pegoraro V, Merico A, Angelini C. Micro-RNAs in ALS muscle: differences in gender, age at onset and disease duration. J Neurolog Sci. 2017;380:58&#x2013;63.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5598142</ArticleId><ArticleId IdType="pubmed">28870590</ArticleId></ArticleIdList></Reference><Reference><Citation>Russell AP, Wada S, Vergani L, Hock MB, Lamon S, L&#xe9;ger B, et al. Disruption of skeletal muscle mitochondrial network genes and miRNAs in amyotrophic lateral sclerosis. Neurobiol Dis. 2013;49:107&#x2013;117.</Citation><ArticleIdList><ArticleId IdType="pubmed">22975021</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams AH, Valdez G, Moresi V, Qi X, McAnally J, Elliott JL, et al. MicroRNA-206 delays ALS progression and promotes regeneration of neuromuscular synapses in mice. Science (New York, NY) 2009;326(5959):1549&#x2013;1554.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2796560</ArticleId><ArticleId IdType="pubmed">20007902</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Pietro L, Lattanzi W, Bernardini C. Skeletal muscle microRNAs as key players in the pathogenesis of amyotrophic lateral sclerosis. Int J Mol Sci. 2018;19(5):1534.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5983603</ArticleId><ArticleId IdType="pubmed">29786645</ArticleId></ArticleIdList></Reference><Reference><Citation>Parisi C, Arisi I, D'Ambrosi N, Storti AE, Brandi R, D'Onofrio M, et al. Dysregulated microRNAs in amyotrophic lateral sclerosis microglia modulate genes linked to neuroinflammation. Cell Death Dis. 2013;4(12):e959.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3877562</ArticleId><ArticleId IdType="pubmed">24336079</ArticleId></ArticleIdList></Reference><Reference><Citation>Cunha C, Santos C, Gomes C, Fernandes A, Correia AM, Sebasti&#xe3;o AM, et al. Downregulated glia interplay and increased miRNA-155 as promising markers to track ALS at an early stage. Mol Neurobiol. 2018;55(5):4207&#x2013;4224.</Citation><ArticleIdList><ArticleId IdType="pubmed">28612258</ArticleId></ArticleIdList></Reference><Reference><Citation>Koval ED, Shaner C, Zhang P, du Maine X, Fischer K, Tay J, et al. Method for widespread microRNA-155 inhibition prolongs survival in ALS-model mice. Hum Mol Genet. 2013;22(20):4127&#x2013;4135.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3781640</ArticleId><ArticleId IdType="pubmed">23740943</ArticleId></ArticleIdList></Reference><Reference><Citation>Butovsky O, Jedrychowski MP, Cialic R, Krasemann S, Murugaiyan G, Fanek Z, et al. Targeting miR-155 restores abnormal microglia and attenuates disease in SOD1 mice. Ann Neurol. 2015;77(1):75&#x2013;99.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4432483</ArticleId><ArticleId IdType="pubmed">25381879</ArticleId></ArticleIdList></Reference><Reference><Citation>Gallo A, Tandon M, Alevizos I, Illei GG. The majority of microRNAs detectable in serum and saliva is concentrated in exosomes. PLOS ONE. 2012;7(3):e30679.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3302865</ArticleId><ArticleId IdType="pubmed">22427800</ArticleId></ArticleIdList></Reference><Reference><Citation>Iftikhar H, Carney GE. Evidence and potential in vivo functions for biofluid miRNAs: from expression profiling to functional testing. BioEssays. 2016;38(4):367&#x2013;378.</Citation><ArticleIdList><ArticleId IdType="pubmed">26934338</ArticleId></ArticleIdList></Reference><Reference><Citation>Turchinovich A, Weiz L, Langheinz A, Burwinkel B. Characterization of extracellular circulating microRNA. Nucleic Acids Res. 2011;39(16):7223&#x2013;7233.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3167594</ArticleId><ArticleId IdType="pubmed">21609964</ArticleId></ArticleIdList></Reference><Reference><Citation>Budnik V, Ruiz-Ca&#xf1;ada C, Wendler F. Extracellular vesicles round off communication in the nervous system. Nat Rev Neurosci. 2016;17:160.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4989863</ArticleId><ArticleId IdType="pubmed">26891626</ArticleId></ArticleIdList></Reference><Reference><Citation>Kr&#xe4;mer-Albers E-M, Hill AF. Extracellular vesicles: interneural shuttles of complex messages. Curr Opin Neurobiol. 2016;39:101&#x2013;107.</Citation><ArticleIdList><ArticleId IdType="pubmed">27183381</ArticleId></ArticleIdList></Reference><Reference><Citation>Cocucci E, Meldolesi J. Ectosomes and exosomes: shedding the confusion between extracellular vesicles. Trends Cell Biol. 2015;25(6):364&#x2013;372.</Citation><ArticleIdList><ArticleId IdType="pubmed">25683921</ArticleId></ArticleIdList></Reference><Reference><Citation>Aucher A, Rudnicka D, Davis DM. MicroRNAs transfer from human macrophages to hepato-carcinoma cells and inhibit proliferation. J Immunol. 2013;191(12):6250.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3858238</ArticleId><ArticleId IdType="pubmed">24227773</ArticleId></ArticleIdList></Reference><Reference><Citation>Dobrenis K, Chang HY, Pina-Benabou MH, Woodroffe A, Lee SC, Rozental R, et al. Human and mouse microglia express connexin36, and functional gap junctions are formed between rodent microglia and neurons. J Neurosci Res. 2005;82(3):306&#x2013;315.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2583240</ArticleId><ArticleId IdType="pubmed">16211561</ArticleId></ArticleIdList></Reference><Reference><Citation>Fabbri M, Paone A, Calore F, Galli R, Gaudio E, Santhanam R, et al. MicroRNAs bind to toll-like receptors to induce prometastatic inflammatory response. Proc Natl Acad Sci. 2012;109(31):E2110.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3412003</ArticleId><ArticleId IdType="pubmed">22753494</ArticleId></ArticleIdList></Reference><Reference><Citation>Coleman LG, Jr, Zou J, Crews FT. Microglial-derived miRNA let-7 and HMGB1 contribute to ethanol-induced neurotoxicity via TLR7. J Neuroinflammation. 2017;14(1):22.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5264311</ArticleId><ArticleId IdType="pubmed">28118842</ArticleId></ArticleIdList></Reference><Reference><Citation>Fabbri M. MicroRNAs and miRceptors: a new mechanism of action for intercellular communication. Philosophical Transactions of the Royal Society B: Biological Sciences. 2018;373(1737):20160486.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5717440</ArticleId><ArticleId IdType="pubmed">29158315</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y, Kim MS, Jia B, Yan J, Zuniga-Hertz JP, Han C, et al. Hypothalamic stem cells control ageing speed partly through exosomal miRNAs. Nature. 2017;548(7665):52&#x2013;57.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5999038</ArticleId><ArticleId IdType="pubmed">28746310</ArticleId></ArticleIdList></Reference><Reference><Citation>Fr&#xfc;hbeis C, Fr&#xf6;hlich D, Kuo WP, Amphornrat J, Thilemann S, Saab AS, et al. Neurotransmitter-triggered transfer of exosomes mediates oligodendrocyte&#x2013;neuron communication. PLOS Biol. 2013;11(7):e1001604.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3706306</ArticleId><ArticleId IdType="pubmed">23874151</ArticleId></ArticleIdList></Reference><Reference><Citation>Ridder K, Keller S, Dams M, Rupp A-K, Schlaudraff J, Del Turco D, et al. Extracellular vesicle-mediated transfer of genetic information between the hematopoietic system and the brain in response to inflammation. PLOS Biol. 2014;12(6):e1001874.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4043485</ArticleId><ArticleId IdType="pubmed">24893313</ArticleId></ArticleIdList></Reference><Reference><Citation>Prada I, Gabrielli M, Turola E, Iorio A, D&#x2019;Arrigo G, Parolisi R, et al. Glia-to-neuron transfer of miRNAs via extracellular vesicles: a new mechanism underlying inflammation-induced synaptic alterations. Acta Neuropathol. 2018;135(4):529&#x2013;550.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5978931</ArticleId><ArticleId IdType="pubmed">29302779</ArticleId></ArticleIdList></Reference><Reference><Citation>Lehmann SM, Kr&#xfc;ger C, Park B, Derkow K, Rosenberger K, Baumgart J, et al. An unconventional role for miRNA: let-7 activates Toll-like receptor 7 and causes neurodegeneration. Nat Neurosci. 2012;15:827.</Citation><ArticleIdList><ArticleId IdType="pubmed">22610069</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramlackhansingh AF, Brooks DJ, Greenwood RJ, Bose SK, Turkheimer FE, Kinnunen KM, et al. Inflammation after trauma: microglial activation and traumatic brain injury. Ann Neurol. 2011;70(3):374&#x2013;383.</Citation><ArticleIdList><ArticleId IdType="pubmed">21710619</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang S, Ge X, Yu J, Han Z, Yin Z, Li Y, et al. Increased miR-124-3p in microglial exosomes following traumatic brain injury inhibits neuronal inflammation and contributes to neurite outgrowth via their transfer into neurons. FASEB J. 2017;32(1):512&#x2013;528.</Citation><ArticleIdList><ArticleId IdType="pubmed">28935818</ArticleId></ArticleIdList></Reference><Reference><Citation>Philips T, Robberecht W. Neuroinflammation in amyotrophic lateral sclerosis: role of glial activation in motor neuron disease. Lancet Neurol. 2011;10(3):253&#x2013;263.</Citation><ArticleIdList><ArticleId IdType="pubmed">21349440</ArticleId></ArticleIdList></Reference><Reference><Citation>Gowing G, Philips T, Van Wijmeersch B, Audet J-N, Dewil M, Van Den Bosch L, et al. Ablation of proliferating microglia does not affect motor neuron degeneration in amyotrophic lateral sclerosis caused by mutant superoxide dismutase. J Neurosci. 2008;28(41):10234.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6671032</ArticleId><ArticleId IdType="pubmed">18842883</ArticleId></ArticleIdList></Reference><Reference><Citation>Janssen HLA, Reesink HW, Lawitz EJ, Zeuzem S, Rodriguez-Torres M, Patel K, et al. Treatment of HCV infection by targeting microRNA. New England J Med. 2013;368(18):1685&#x2013;1694.</Citation><ArticleIdList><ArticleId IdType="pubmed">23534542</ArticleId></ArticleIdList></Reference><Reference><Citation>Beg MS, Brenner AJ, Sachdev J, Borad M, Kang Y-K, Stoudemire J, et al. Phase I study of MRX34, a liposomal miR-34a mimic, administered twice weekly in patients with advanced solid tumors. Invest New Drugs. 2017;35(2):180&#x2013;188.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5893501</ArticleId><ArticleId IdType="pubmed">27917453</ArticleId></ArticleIdList></Reference><Reference><Citation>Fumagalli M, Lombardi M, Gressens P, Verderio C. How to reprogram microglia toward beneficial functions. Glia. 2018;66(12):2531&#x2013;2549.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6585737</ArticleId><ArticleId IdType="pubmed">30195261</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>